Ephedra-containing oriental cold drugs in dispute

Published: 2004-08-17 07:00:00

Updated: 2004-08-17 07:00:00

Recently, the Korea Doctors for Democratic Society claimed that a large amount of oriental cold remedies containing ephedra has been without restriction released to the market as OTC products and called on the government to reclassify them into prescription drugs based on the previous report of t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK